Disc Medicine, Inc. (IRON) stock
IRONNasdaqPharmaceutical PreparationsFiscal year ends December 31
$76.57−0.02 (-0.03%)
Close on Nov 17, 2026Market cap $2.94BP/E –Yield –
Disc Medicine enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Disc Medicine's enterprise value was $2.62B on Nov 11, 2026, against $2.65B a year earlier. Over the last 5 years it ranged from -$75.84M to $2.65B, with a median of $986.03M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $2.62B | +21.1% |
| 2025 | Dec 31, 2025 | $2.16B | +54.7% |
| 2024 | Dec 31, 2024 | $1.40B | +36.6% |
| 2023 | Dec 29, 2023 | $1.02B | +27.1% |
| 2022 | Dec 30, 2022 | $805.58M | -27.0% |
| 2021 | Dec 31, 2021 | $1.10B | – |
See a number that looks wrong?